Medication Overview
Client Psychiatric/Admitting Diagnosis: __________________________________
| Medication & Drug Classification | Route/Dose/Frequency | Purpose | Major Side Effects | Nursing Interventions | 
|---|---|---|---|---|
| Fluoxetine (Prozac) SSRIs (Selective Serotonin Reuptake Inhibitor) | Oral: 20-80 mg daily | 1. Major depressive disorder 2. OCD 3. Panic disorder 4. Bulimia | 1. Nausea 2. Insomnia 3. Sexual dysfunction | 1. Monitor for suicidal ideation, especially in younger patients 2. Educate about delayed onset (2-4 weeks) 3. Avoid abrupt discontinuation to prevent withdrawal symptoms | 
| Sertraline (Zoloft) SSRIs (Selective Serotonin Reuptake Inhibitor) | Oral: 50-200 mg daily | 1. Depression 2. PTSD 3. Social anxiety 4. OCD | 1. GI upset 2. Drowsiness 3. Weight changes | 1. Monitor for serotonin syndrome (agitation, confusion, sweating) 2. Advise taking with food to reduce GI effects 3. Educate about sexual dysfunction potential | 
| Venlafaxine (Effexor) SNRIs (Serotonin-Norepinephrine Reuptake Inhibitor) | Oral: 37.5-225 mg daily | 1. Major depressive disorder 2. Generalized anxiety 3. Panic disorder | 1. Increased blood pressure 2. Headache 3. Sweating | 1. Monitor blood pressure regularly 2. Warn about withdrawal effects if stopped abruptly 3. Encourage hydration due to sweating | 
| Bupropion (Wellbutrin) Atypical Antidepressant | Oral: 150-450 mg daily | 1. Depression 2. Smoking cessation 3. Seasonal affective disorder | 1. Insomnia 2. Dry mouth 3. Seizure risk | 1. Avoid in patients with a history of seizures or eating disorders 2. Take in the morning to reduce insomnia 3. Monitor for increased anxiety or agitation | 
| Risperidone (Risperdal) Atypical Antipsychotic | Oral/IM: 0.5-6 mg daily | 1. Schizophrenia 2. Bipolar disorder 3. Autism-related irritability | 1. Weight gain 2. Sedation 3. Increased prolactin | 1. Monitor for extrapyramidal symptoms (EPS) 2. Encourage a healthy diet and exercise 3. Educate about sedation effects and caution with driving | 
| Lithium Mood Stabilizer | Oral: 600-1800 mg daily in divided doses | 1. Bipolar disorder 2. Mania prevention | 1. Tremors 2. Polyuria 3. Hypothyroidism | 1. Monitor serum lithium levels (0.6-1.2 mEq/L) 2. Educate about adequate fluid and sodium intake 3. Assess for toxicity signs (confusion, diarrhea, tremors) | 
| Propranolol Beta Blocker | 10-40/60 mg for Nightmares/General symptoms | 1. Intrusive symptoms (PTSD) | 1. Fatigue 2. Dizziness 3. Bradycardia | 1. Monitor vitals (BP & HR) 2. Assess for symptom progression/worsening 3. Educate patient on the risks of stopping abruptly |